36987-1845 : Standardized Mite Dermatophagoides Pteronyssinus 10000 [au]/Ml Intradermal; Subcutaneous Injection, Solution


NDC: 36987-1845
Labeler: Nelco Laboratories, Inc.
Product Type: Human Prescription Drug
Drug Name: Standardized Mite Dermatophagoides Pteronyssinus
Dosage Form: Intradermal; Subcutaneous Injection, Solution
Application #: BLA102194
Rev. Date: 


NDC Package Codes:

  • 36987-1845-1: 5 ML IN 1 VIAL, MULTI‑DOSE (36987‑1845‑1)
  • 36987-1845-2: 10 ML IN 1 VIAL, MULTI‑DOSE (36987‑1845‑2)
  • 36987-1845-3: 30 ML IN 1 VIAL, MULTI‑DOSE (36987‑1845‑3)
  • 36987-1845-4: 50 ML IN 1 VIAL, MULTI‑DOSE (36987‑1845‑4)

Active Ingredients:

  • Dermatophagoides Pteronyssinus

Dosage Strength:

  • 10000 [AU]/mL

Pharmaceutical Classes:

  • Standardized Insect Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Antigens
  • Dermatophagoides [CS]
  • Insect Proteins [CS]
  • Allergens [CS]

Related Products:

Based on records with the same trade name.
  • 49288-0172 Standardized Mite, Dermatophagoides Pteronyssinus 10000 [au]/Ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
  • 49288-0173 Standardized Mite, Dermatophagoides Pteronyssinus 3000 [au]/Ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
  • 49288-0174 Standardized Mite, Dermatophagoides Pteronyssinus 5000 [au]/Ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 36987-1845 QR Code

< Prev: 36987-1844Next: 36987-1846 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.